125,000 Shares in Walgreens Boots Alliance, Inc. $WBA Purchased by Vazirani Asset Management LLC

Key Points

• Vazirani Asset Management LLC purchased 125,000 shares of Walgreens Boots Alliance, valued at approximately $202,000, making it the firm's 15th largest holding.
• Walgreens Boots Alliance reported earnings of $0.38 EPS in its recent quarter, surpassing analysts' expectations of $0.34, along with a revenue of $38.99 billion.
• Institutional investors and hedge funds own 58.59% of Walgreens Boots Alliance stock, indicating strong interest from large stakeholders.

Vazirani Asset Management LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 125,000 shares of the pharmacy operator's stock, valued at approximately $202,000. Walgreens Boots Alliance accounts for about 0.7% of Vazirani Asset Management LLC's portfolio, making the stock its 15th biggest position.

Several other hedge funds have also recently modified their holdings of WBA. Curat Global LLC acquired a new stake in Walgreens Boots Alliance in the first quarter worth about $27,000. Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance during the first quarter valued at $27,000. Colonial Trust Co SC increased its holdings in Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,297 shares in the last quarter. Federated Hermes Inc. lifted its position in shares of Walgreens Boots Alliance by 135.8% in the first quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after acquiring an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC acquired a new position in Walgreens Boots Alliance during the first quarter worth about $43,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA remained flat at $11.98 during midday trading on Wednesday. The company has a market capitalization of $10.37 billion, a P/E ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $13.25. The company's 50 day moving average is $11.71 and its 200 day moving average is $11.29.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to analysts' expectations of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business's revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.63 EPS. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on WBA. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a "hold" rating on the stock. UBS Group restated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Reduce" and an average price target of $10.15.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.